COA AX-2026-2033-25BA matches Axiom Analytics's public record. So this test doesn't rest on our review alone — the lab confirms it too.
2529-B886-B1E2This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 30 mg · Lab measured 31.65 mg
106% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 7.9 mg using the measured mass, against 7.5 mg on the label — 6% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | AX-2026-2033-25BA |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Axiom Analytics's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by Axiom Analytics on September 19, 2026. Reported purity: 99.87%. Net content: 31.65 mg against 30 mg labeled (106% of label). Endotoxins: 0.069 EU/mg - PASS. Batch TR302603. Sample source: shop-provided. Certificate of analysis attached.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion